Autonomous AI agents are capable of designing a wide range of biotech products, including diagnostics, vaccines, and gene or cell therapies, based on any project description or specific requirements. These agents leverage a variety of resources, such as bioinformatics tools, databases, computational simulations, and scientific literature, to develop cutting-edge solutions. By integrating advanced algorithms and real-time data analysis, the AI agents can optimize product designs for efficacy, safety, and scalability, significantly accelerating the innovation process and reducing development time in biotechnology.